Changes in expression of P2X₇ receptors in NOD mouse pancreas during the development of diabetes

References

• Adorini L, Gregori S, Harrison LC. Understanding autoimmune diabetes: Insights from mouse models. Trends Mol Med 2002; 8: 31–38
   PubMed Web of Science ®Google Scholar
• Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995; 13: 179–200
   PubMed Web of Science ®Google Scholar
• Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA. Immunohistochemical characterization of monocytes–macrophages and dendritic cells involved in the initiation of the insulitis and beta- cell destruction in NOD mice. Diabetes 1994; 43: 667–675
   PubMed Web of Science ®Google Scholar
• Rosmalen JG, Homo-Delarche F, Durant S, Kap M, Leenen PJ, Drexhage HA. Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NOD scid mice. Lab Invest 2000; 80: 769–777
   PubMedGoogle Scholar
• Rosmalen JG, Martin T, Dobbs C, Voerman JS, Drexhage HA, Haskins K, Leenen PJ. Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: Correlation with the development of diabetes. Lab Invest 2000; 80: 23–30
   PubMedGoogle Scholar
• Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 1996; 272: 735–738
   PubMed Web of Science ®Google Scholar
• Gröschel-Stewart U, Bardini M, Robson T, Burnstock G. Localisation of P2X5 and P2X7 receptors by immunohistochemistry in rat stratified squamous epithelia. Cell Tissue Res 1999; 296: 599–605
   PubMedGoogle Scholar
• Gröschel-Stewart U, Bardini M, Robson T, Burnstock G. P2X receptors in the rat duodenal villus. Cell Tissue Res 1999; 297: 111–117
   PubMedGoogle Scholar
• Greig AVH, Linge C, Healy V, Lim P, Clayton E, Rustin MH, McGrouther DA, Burnstock G. Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Invest Dermatol 2003; 121: 315–327
   PubMed Web of Science ®Google Scholar
• Coutinho-Silva R, Alves LA, de Carvalho AC, Savino W, Persechini PM. Characterization of P2Z purinergic receptors on phagocytic cells of the thymic reticulum in culture. Biochim Biophys Acta 1996; 1280: 217–222
   PubMedGoogle Scholar
• Coutinho-Silva R, Persechini PM, Bisaggio RD, Perfettini JL, Neto AC, Kanellopoulos JM, Motta-Ly I, Dautry-Varsat A, Ojcius DM. P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Physiol 1999; 276: C1139–C1147
   PubMed Web of Science ®Google Scholar
• Nihei OK, de Carvalho AC, Savino W, Alves LA. Pharmacologic properties of P(2Z)/P2X7 receptor characterized in murine dendritic cells: Role on the induction of apoptosis. Blood 2000; 96: 996–1005
   PubMedGoogle Scholar
• Falzoni S, Chiozzi P, Ferrari D, Buell G, Di Virgilio F. P2X7 receptor and polykarion formation. Mol Biol Cell 2000; 11: 3169–3176
   PubMedGoogle Scholar
• Lammas DA, Stober C, Harvey CJ, Kendrick N, Panchalingam S, Kumararatne DS. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 1997; 7: 433–444
   PubMed Web of Science ®Google Scholar
• Stober CB, Lammas DA, Li CM, Kumararatne DS, Lightman SL, McArdle CA. ATP-mediated killing of mycobacterium bovis bacille Calmette–Guerin within human macrophages is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes. J Immunol 2001; 166: 6276–6286
   PubMedGoogle Scholar
• Coutinho-Silva R, Perfettini JL, Persechini PM, Dautry-Varsat A, Ojcius DM. Modulation of P2Z/P2X7 receptor activity in macrophages infected with chlamydia psittaci. Am J Physiol 2001; 280: C81–C89
   Google Scholar
• Coutinho-Silva R, Stahl L, Raymond M-N, Jungas T, Verbeke P, Burnstock G, Darville T, Ojcius DC. Inhibition of chlamydial infectious activity due to P2XR-dependent phospholipase D activation. Immunity 2003; 19: 403–412
   PubMed Web of Science ®Google Scholar
• Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA. Altered cytokine production in mice lacking P2X7 receptors. J Biol Chem 2001; 276: 125–132
   PubMed Web of Science ®Google Scholar
• Le Feuvre R, Brough D, Rothwell N. Extracellular ATP and P2X7 receptors in neurodegeneration. Eur J Pharmacol 2002; 447: 261–269
   PubMedGoogle Scholar
• Di Virgilio F. The P2Z purinoceptor: An intriguing role in immunity, inflammation and cell death. Immunol Today 1995; 16: 524–528
   PubMedGoogle Scholar
• Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR. Nucleotide receptors: An emerging family of regulatory molecules in blood cells. Blood 2001; 97: 587–600
   PubMed Web of Science ®Google Scholar
• Sandler S, Andersson A, Hellerstrom C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424–1431
   PubMed Web of Science ®Google Scholar
• Pavlovic D, Andersen NA, Mandrup-Poulsen T, Eizirik DL. Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic β-cells. Eur Cytokine Netw 2000; 11: 267–274
   PubMed Web of Science ®Google Scholar
• Ammendrup A, Maillard A, Nielsen K, Aabenhus AN, Serup P, Dragsbaek MO, Mandrup-Poulsen T, Bonny C. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells. Diabetes 2000; 49: 1468–1476
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Mandrup-Poulsen T. A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 2001; 44: 2115–2133
   PubMed Web of Science ®Google Scholar
• Hoorens A, Stange G, Pavlovic D, Pipeleers D. Distinction between interleukin-1-induced necrosis and apoptosis of islet cells. Diabetes 2001; 50: 551–557
   PubMedGoogle Scholar
• Reddy S, Bradley J, Ginn S, Pathipati P, Ross JM. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes. Histochem Cell Biol 2003; 119: 451–461
   PubMed Web of Science ®Google Scholar
• Signore A, Pozzilli P, Gale EA, Andreani D, Beverley PC. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia 1989; 32: 282–289
   PubMed Web of Science ®Google Scholar
• Oglesby IB, Lachnit WG, Burnstock G, Ford APDW. Subunit specificity of polyclonal antisera to the carboxy terminal regions of P2X receptors, P2X1 through P2X7. Drug Dev Res 1999; 47: 189–195
   Google Scholar
• Llewellyn-Smith IJ, Pilowsky P, Minson JB. The tungstate-stabilized tetramethylbenzidine reaction for light and electron microscopic immunocytochemistry and for revealing biocytin-filled neurons. J Neurosci Methods 1993; 46: 27–40
   PubMedGoogle Scholar
• Takamura T, Ando H, Nagai Y, Yamashita H, Nohara E, Kobayashi K. Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes. Diabetes Res Clin Pract 1999; 44: 107–114
   PubMedGoogle Scholar
• Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 1999; 189: 331–339
   PubMed Web of Science ®Google Scholar
• Coutinho-Silva R, Parsons M, Robson T, Burnstock G. Changes in expression of P2 receptors in rat and mouse pancreas during development and aging. Cell Tissue Res 2001; 306: 373–383
   PubMedGoogle Scholar
• Reddy S, Pathipati P, Bai Y, Robinson E, Ross JM. Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: A combined immunohistochemical and histochemical study. J Mol Histol 2005; 36: 289–300
   PubMedGoogle Scholar
• Coutinho-Silva R, Parsons M, Robson T, Lincoln J, Burnstock G. P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats. Mol Cell Endocrinol 2003; 204: 141–154
   PubMedGoogle Scholar
• Riley WJ, McConnell TJ, Maclaren NK, McLaughlin JV, Taylor G. The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age. Diabetes 1981; 30: 718–723
   PubMedGoogle Scholar
• Kim BM, Han YM, Shin YJ, Min BH, Park IS. Clusterin expression during regeneration of pancreatic islet cells in streptozotocin-induced diabetic rats. Diabetologia 2001; 44: 2192–2202
   PubMed Web of Science ®Google Scholar
• Fraser RB, Rowden G, Colp P, Wright JR. Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin. Diabetologia 1997; 40: 1263–1268
   PubMedGoogle Scholar
• Humphreys BD, Dubyak GR. Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-γ in the human THP-1 monocytic cell line. J Immunol 1996; 157: 5627–5637
   PubMedGoogle Scholar
• Mutini C, Falzoni S, Ferrari D, Chiozzi P, Morelli A, Baricordi OR, Collo G, Ricciardi-Castagnoli P, Di Virgilio F. Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation. J Immunol 1999; 163: 1958–1965
   PubMedGoogle Scholar
• Gudipaty L, Humphreys BD, Buell G, Dubyak GR. Regulation of P2X7 nucleotide receptor function in human monocytes by extracellular ions and receptor density. Am J Physiol Cell Physiol 2001; 280: C943–C953
   PubMedGoogle Scholar
• Novak I. ATP as a signaling molecule: The exocrine focus. News Physiol Sci 2003; 18: 12–17
   PubMedGoogle Scholar
• Fernandez-Alvarez J, Hillaire-Buys D, Loubatières-Mariani MM, Gomis R, Petit P. P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas 2001; 22: 69–71
   PubMed Web of Science ®Google Scholar
• Chevassus H, Roig A, Belloc C, Lajoix AD, Broca C, Manteghetti M, Petit P. P2Y receptor activation enhances insulin release from pancreatic β-cells by triggering the cyclic AMP/protein kinase a pathway. Naunyn Schmiedeberg's Arch Pharmacol 2002; 366: 464–469
   Google Scholar
• Elliott JI, Higgins CF. Major histocompatibility complex class I shedding and programmed cell death stimulated through the proinflammatory P2X7 receptor: A candidate susceptibility gene for NOD diabetes. Diabetes 2004; 53: 2012–2017
   PubMedGoogle Scholar
• O'Brien BA, Huang Y, Geng X, Dutz JP, Finegood DT. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 2002; 51: 2481–2488
   PubMed Web of Science ®Google Scholar